1. Home
  2. LXRX vs CEP Comparison

LXRX vs CEP Comparison

Compare LXRX & CEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LXRX
  • CEP
  • Stock Information
  • Founded
  • LXRX 1995
  • CEP 2020
  • Country
  • LXRX United States
  • CEP United States
  • Employees
  • LXRX N/A
  • CEP N/A
  • Industry
  • LXRX Biotechnology: Pharmaceutical Preparations
  • CEP
  • Sector
  • LXRX Health Care
  • CEP
  • Exchange
  • LXRX Nasdaq
  • CEP NYSE
  • Market Cap
  • LXRX 124.4M
  • CEP 131.6M
  • IPO Year
  • LXRX 2000
  • CEP 2024
  • Fundamental
  • Price
  • LXRX $0.70
  • CEP $31.51
  • Analyst Decision
  • LXRX Buy
  • CEP
  • Analyst Count
  • LXRX 4
  • CEP 0
  • Target Price
  • LXRX $3.67
  • CEP N/A
  • AVG Volume (30 Days)
  • LXRX 5.7M
  • CEP 8.6M
  • Earning Date
  • LXRX 05-13-2025
  • CEP 01-01-0001
  • Dividend Yield
  • LXRX N/A
  • CEP N/A
  • EPS Growth
  • LXRX N/A
  • CEP N/A
  • EPS
  • LXRX N/A
  • CEP 0.24
  • Revenue
  • LXRX $31,081,000.00
  • CEP N/A
  • Revenue This Year
  • LXRX N/A
  • CEP N/A
  • Revenue Next Year
  • LXRX $84.78
  • CEP N/A
  • P/E Ratio
  • LXRX N/A
  • CEP $131.96
  • Revenue Growth
  • LXRX 2481.48
  • CEP N/A
  • 52 Week Low
  • LXRX $0.28
  • CEP $9.99
  • 52 Week High
  • LXRX $2.45
  • CEP $59.75
  • Technical
  • Relative Strength Index (RSI)
  • LXRX 60.07
  • CEP N/A
  • Support Level
  • LXRX $0.63
  • CEP N/A
  • Resistance Level
  • LXRX $0.71
  • CEP N/A
  • Average True Range (ATR)
  • LXRX 0.07
  • CEP 0.00
  • MACD
  • LXRX -0.00
  • CEP 0.00
  • Stochastic Oscillator
  • LXRX 55.00
  • CEP 0.00

About LXRX Lexicon Pharmaceuticals Inc.

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain; and sotagliflozin, an orally-delivered small molecule drug candidate, as a treatment for heart failure and type 1 diabetes.

About CEP CANTOR EQUITY PARTNERS INC

Cantor Equity Partners Inc is a blank check company.

Share on Social Networks: